Literature DB >> 23904013

The Global Burden of Disease 2010 Study: what does it tell us about mental disorders in Latin America?

Harvey A Whiteford, Amanda J Baxter.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 23904013     DOI： 10.1590/1516-4446-2012-3502

Source DB:  PubMed          Journal:  Braz J Psychiatry        ISSN： 1516-4446            Impact factor:   2.697


× No keyword cloud information.
  10 in total

1.  Big data and meaning: methodological innovations.

Authors:  K S Bhui
Journal:  Epidemiol Psychiatr Sci       Date:  2015-01-30       Impact factor: 6.892

2.  From genes to treatments: a systematic review of the pharmacogenetics in smoking cessation.

Authors:  Naji C Salloum; Erica L F Buchalter; Swati Chanani; Gemma Espejo; Mahjabeen S Ismail; Randy O Laine; Maysaa Nageeb; A Benjamin Srivastava; Nicholas Trapp; Ludwig Trillo; Erica Vance; Michael Wenzinger; Sarah M Hartz; Sean P David; Li-Shiun Chen
Journal:  Pharmacogenomics       Date:  2018-06-19       Impact factor: 2.533

3.  Genetic variation (CHRNA5), medication (combination nicotine replacement therapy vs. varenicline), and smoking cessation.

Authors:  Li-Shiun Chen; Timothy B Baker; Douglas Jorenby; Megan Piper; Nancy Saccone; Eric Johnson; Naomi Breslau; Dorothy Hatsukami; Robert M Carney; Laura J Bierut
Journal:  Drug Alcohol Depend       Date:  2015-06-23       Impact factor: 4.492

4.  Smoking Cessation and Electronic Cigarettes in Community Mental Health Centers: Patient and Provider Perspectives.

Authors:  Li-Shiun Chen; Timothy Baker; Ross C Brownson; Robert M Carney; Douglas Jorenby; Sarah Hartz; Nina Smock; Mark Johnson; Douglas Ziedonis; Laura J Bierut
Journal:  Community Ment Health J       Date:  2016-11-30

Review 5.  Pathways to precision medicine in smoking cessation treatments.

Authors:  Li-Shiun Chen; Amy Horton; Laura Bierut
Journal:  Neurosci Lett       Date:  2016-05-18       Impact factor: 3.046

Review 6.  Leveraging Genomic Data in Smoking Cessation Trials in the Era of Precision Medicine: Why and How.

Authors:  Li-Shiun Chen; Laurie Zawertailo; Thomas M Piasecki; Jaakko Kaprio; Marilyn Foreman; Hannah R Elliott; Sean P David; Andrew W Bergen; James W Baurley; Rachel F Tyndale; Timothy B Baker; Laura J Bierut; Nancy L Saccone
Journal:  Nicotine Tob Res       Date:  2018-03-06       Impact factor: 4.244

7.  Feasibility of mHealth interventions for depressive symptoms in Latin America: a systematic review.

Authors:  César G Escobar-Viera; Luca C Cernuzzi; Rebekah S Miller; Hugo J Rodríguez-Marín; Eduard Vieta; Magalí González Toñánez; Lisa A Marsch; Diego Hidalgo-Mazzei
Journal:  Int Rev Psychiatry       Date:  2021-06-09

8.  Intranasal administration of a stapled relaxin-3 mimetic has anxiolytic- and antidepressant-like activity in rats.

Authors:  Subhi Marwari; Anders Poulsen; Norrapat Shih; Rajamani Lakshminarayanan; R Manjunatha Kini; Charles William Johannes; Brian William Dymock; Gavin Stewart Dawe
Journal:  Br J Pharmacol       Date:  2019-09-11       Impact factor: 8.739

9.  Feasibility of an interactive voice response system for monitoring depressive symptoms in a lower-middle income Latin American country.

Authors:  Mary R Janevic; Amparo C Aruquipa Yujra; Nicolle Marinec; Juvenal Aguilar; James E Aikens; Rosa Tarrazona; John D Piette
Journal:  Int J Ment Health Syst       Date:  2016-09-22

Review 10.  Is psychosis a multisystem disorder? A meta-review of central nervous system, immune, cardiometabolic, and endocrine alterations in first-episode psychosis and perspective on potential models.

Authors:  Toby Pillinger; Enrico D'Ambrosio; Robert McCutcheon; Oliver D Howes
Journal:  Mol Psychiatry       Date:  2018-05-09       Impact factor: 15.992
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.